Viewing StudyNCT02579616



Ignite Creation Date: 2024-05-06 @ 7:40 AM
Last Modification Date: 2024-10-26 @ 11:51 AM
Study NCT ID: NCT02579616
Status: COMPLETED
Last Update Posted: 2020-12-23
First Post: 2015-10-16

Brief Title: Study of Lenvatinib E7080 in Unresectable Biliary Tract Cancer BTC Who Failed Gemcitabine-based Combination Chemotherapy
Sponsor: Eisai Co Ltd
Organization: Eisai Inc

Conditions & Keywords Data

Conditions:
Name
Biliary Tract Cancer
Keywords:
Name View
Lenvima View
Lenvatinib View
E7080 View
Unresectable biliary tract cancer View
BTC View
Gemcitabine-based combination chemotherapy View